Literature DB >> 26986067

Adverse events following immunization: real causality and myths.

Nicola Principi1, Susanna Esposito1.   

Abstract

INTRODUCTION: To assure the highest safety of immunization programs, detect adverse events following immunization (AEFIs), eliminate concerns, and reduce the risk of low vaccination coverage, authorities in industrialized countries have collected years of reports of suspected AEFIs and have systematically assessed their clinical importance. AREAS COVERED: In this paper, the methods used to assess vaccine safety and the results obtained by the analysis of reports, studies, and meta-analyses are discussed. EXPERT OPINION: Severe AEFIs are rare, and all evaluations of safety of vaccines recommended for both children and adults have demonstrated that the advantages of vaccines are always significantly higher than the problems that they cause, and there is no need to modify recommendations. However, the definition of AEFI is dependent on the vaccines themselves, complicating the definition of an AEFI and explaining why doubts and concerns have been raised. Presently, disease epidemiology data collected in healthy people and in subjects with underlying disease, general vaccine coverage, and the vaccination status of subjects with AEFIs are managed by many independent institutions. Only strict co-operation between these institutions will lead to the successful identification of AEFIs and to a reduction of the weight of anti-vaccine arguments.

Entities:  

Keywords:  AEFI; adverse event; immunization; prevention; reactogenicity; tolerability; vaccine

Mesh:

Substances:

Year:  2016        PMID: 26986067     DOI: 10.1517/14740338.2016.1167869

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  12 in total

1.  Measles vaccination of special risk groups.

Authors:  Vassiliki Papaevangelou
Journal:  Hum Vaccin Immunother       Date:  2021-11-17       Impact factor: 3.452

2.  Retrospective study of immunization errors reported in an online Information System.

Authors:  Tânia Cristina Barboza; Rafael Alves Guimarães; Fernanda Raphael Escobar Gimenes; Ana Elisa Bauer de Camargo Silva
Journal:  Rev Lat Am Enfermagem       Date:  2020-06-19

3.  Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization's Reporting? A Pharmacovigilance Study in Southern Italy.

Authors:  Cristina Scavone; Concetta Rafaniello; Simona Brusco; Michele Bertini; Enrica Menditto; Valentina Orlando; Ugo Trama; Liberata Sportiello; Francesco Rossi; Annalisa Capuano
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

4.  Adverse Events Following Immunization in Brazil: Age of Child and Vaccine-Associated Risk Analysis Using Logistic Regression.

Authors:  Sílvia R C Lopes; João L R Perin; Taiane S Prass; Sandra Maria D Carvalho; Sérgio C Lessa; José G Dórea
Journal:  Int J Environ Res Public Health       Date:  2018-06-01       Impact factor: 3.390

5.  Adverse Events Following Measles-Mumps-Rubella-Varicella Vaccination and the Case of Seizures: A Post Marketing Active Surveillance in Puglia Italian Region, 2017-2018.

Authors:  Pasquale Stefanizzi; Paolo Stella; Domenica Ancona; Katia Nicoletta Malcangi; Francesco Paolo Bianchi; Sara De Nitto; Davide Ferorelli; Cinzia Annatea Germinario; Silvio Tafuri
Journal:  Vaccines (Basel)       Date:  2019-10-07

Review 6.  Vitamin D Deficiency During Pregnancy and Autism Spectrum Disorders Development.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Front Psychiatry       Date:  2020-01-31       Impact factor: 4.157

7.  Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data.

Authors:  Paolo Bellavite; Alberto Donzelli
Journal:  F1000Res       Date:  2020-09-28

Review 8.  Do Vaccines Have a Role as a Cause of Autoimmune Neurological Syndromes?

Authors:  Nicola Principi; Susanna Esposito
Journal:  Front Public Health       Date:  2020-07-28

9.  Ten years of vaccinovigilance in Italy: an overview of the pharmacovigilance data from 2008 to 2017.

Authors:  F Moretti; L Gonella; S Gironi; A R Marra; C Santuccio; P Felicetti; F Petronzelli; P Marchione; S A Barnaba; A Poli; G Zanoni; U Moretti
Journal:  Sci Rep       Date:  2020-08-24       Impact factor: 4.379

10.  Post-marketing surveillance of adverse events following measles, mumps, rubella and varicella (MMRV) vaccine: retrospecive study in apulia region (ITALY), 2009-2017.

Authors:  Pasquale Stefanizzi; Sara De Nitto; Francesco Patano; Francesco Paolo Bianchi; Davide Ferorelli; Paolo Stella; Domenica Ancona; Vito Bavaro; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2020-02-10       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.